Alison  Ives net worth and biography

Alison Ives Biography and Net Worth

EVP of Perrigo
Alison Ives was appointed Executive Vice President and Chief Scientific Officer in June 2022. Ms. Ives previously served in roles of increasing responsibility, including Vice President Regulatory Affairs, Consumer Self-Care International from December 2017 to September 2020 and Vice President, Consumer Self-Care Americas, from September 2020 until May 2022. Ms. Ives joined Perrigo through the acquisition of Omega Pharma, where she worked for five years building a Regulatory Affairs function and new product pipeline. Ms. Ives also worked with AstraZeneca for 11 years in a variety of regional and global leadership roles within the Scientific office, while sitting on new product development teams across five therapeutic areas. Her career achievements have been recognized externally by receiving a prestigious MBE award from the UK government for services to healthcare, reflecting her lifelong passion to make lives better.

What is Alison Ives' net worth?

The estimated net worth of Alison Ives is at least $432,956.31 as of March 5th, 2024. Ms. Ives owns 16,122 shares of Perrigo stock worth more than $432,956 as of June 15th. This net worth estimate does not reflect any other investments that Ms. Ives may own. Learn More about Alison Ives' net worth.

How old is Alison Ives?

Ms. Ives is currently 43 years old. There are 5 older executives and no younger executives at Perrigo. The oldest executive at Perrigo is Mr. Svend Andersen, Executive VP & President of Consumer Self-Care International, who is 62 years old. Learn More on Alison Ives' age.

How do I contact Alison Ives?

The corporate mailing address for Ms. Ives and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Alison Ives' contact information.

Has Alison Ives been buying or selling shares of Perrigo?

Alison Ives has not been actively trading shares of Perrigo during the last ninety days. Most recently, on Tuesday, March 5th, Alison Ives bought 2,490 shares of Perrigo stock. The stock was acquired at an average cost of $27.26 per share, with a total value of $67,877.40. Following the completion of the transaction, the executive vice president now directly owns 16,122 shares of the company's stock, valued at $439,485.72. Learn More on Alison Ives' trading history.

Who are Perrigo's active insiders?

Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Patrick Lockwood-Taylor (CEO), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.

Are insiders buying or selling shares of Perrigo?

During the last twelve months, Perrigo insiders bought shares 8 times. They purchased a total of 42,580 shares worth more than $1,199,876.50. The most recent insider tranaction occured on May, 28th when EVP Svend Andersen bought 1,000 shares worth more than $27,900.00. Insiders at Perrigo own 0.7% of the company. Learn More about insider trades at Perrigo.

Information on this page was last updated on 5/28/2024.

Alison Ives Insider Trading History at Perrigo

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2024Buy2,490$27.26$67,877.4016,122View SEC Filing Icon  
11/16/2023Buy2,040$29.34$59,853.6010,380View SEC Filing Icon  
See Full Table

Alison Ives Buying and Selling Activity at Perrigo

This chart shows Alison Ives's buying and selling at Perrigo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perrigo Company Overview

Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $26.86
Low: $26.59
High: $27.36

50 Day Range

MA: $29.88
Low: $26.39
High: $33.43

2 Week Range

Now: $26.86
Low: $25.77
High: $40.28

Volume

1,461,795 shs

Average Volume

1,705,296 shs

Market Capitalization

$3.66 billion

P/E Ratio

N/A

Dividend Yield

4.03%

Beta

0.56